Hologic Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 51/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 75.36.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Hologic Inc's Score
Industry at a Glance
Industry Ranking
51 / 208
Overall Ranking
134 / 4592
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
19
analysts
Hold
Current Rating
75.357
Target Price
+0.68%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Hologic Inc Highlights
StrengthsRisks
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 4.10B.
Fairly Valued
The company’s latest PE is 29.98, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 223.55M shares, decreasing 6.02% quarter-over-quarter.
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Ticker SymbolHOLX
CompanyHologic Inc
CEOMacmillan (Stephen P)
Websitehttps://www.hologic.com/
FAQs
What is the current price of Hologic Inc (HOLX)?
The current price of Hologic Inc (HOLX) is 75.106.
What is the symbol of Hologic Inc?
The ticker symbol of Hologic Inc is HOLX.
What is the 52-week high of Hologic Inc?
The 52-week high of Hologic Inc is 75.300.
What is the 52-week low of Hologic Inc?
The 52-week low of Hologic Inc is 51.900.
What is the market capitalization of Hologic Inc?
The market capitalization of Hologic Inc is 16.72B.
What is the net income of Hologic Inc?
The net income of Hologic Inc is 565.70M.
Is Hologic Inc (HOLX) currently rated as Buy, Hold, or Sell?
According to analysts, Hologic Inc (HOLX) has an overall rating of Hold, with a price target of 75.357.
What is the Earnings Per Share (EPS TTM) of Hologic Inc (HOLX)?
The Earnings Per Share (EPS TTM) of Hologic Inc (HOLX) is 2.501.